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Executive Summary
There are calls for widespread scaling up of remote care – ‘telehealth’ 
and ‘telecare’. These are driven by an ageing population, increasing 
numbers of people with chronic conditions and constrained resources 
available for health and social services. 
This report is concerned with the supply-side of 
remote care and its ability to meet anticipated 
future needs. This is an important, but overlooked, 
question in the debate, which usually concentrates 
on demand-side issues such as the fragmentation 
of the health and social care system, or 
commissioning and funding issues.
Since 2006 the UK’s various policy initiatives 
probably represent the most important concerted 
effort by a national government to stimulate the 
uptake of remote care. At least £160m of public 
funding was spent across the UK during 2006-
2011.
Little is known about the number of people who use 
remote care systems at any given time. We estimate 
that, in the UK, there may be around 350,000 users 
of systems that are more sophisticated than a basic 
pendant alarm. 
We know even less about the potential number 
of remote care users because this figure depends 
on assumptions made about remote care’s 
effectiveness and the size of the population that 
could benefit from it. 
Focusing just on the population over 75 years old, 
there may be a current potential market of 1.4m 
users, assuming that 80 per cent wish to live at 
home as long as possible and a third might benefit 
from remote care. This number could grow to 3.2m 
by 2050. 
Many of the current barriers to remote care 
expansion involve a mix of demand-side factors, but 
there are also significant problems with the supply 
industry’s structure.
Familiar demand-side problems include:
inadequate evidence for the benefits of remote 
care; fragmentation of purchasing and silo-
based behaviour; poor integration across health 
and social care services; weak leadership in the 
NHS to overcome general resistance and drive 
developments; lack of expertise among NHS 
purchasers, hampering collaborative relationships; 
problems with the remote care procurement 
framework for public sector organisations; lack of 
suitable models for reimbursing the costs of  
remote care.
Problems on the supply-side include:
the small-scale and fragmented nature of the 
industry; difficulties in identifying suitable business 
models, compounded by a lack of evidence for the 
benefits; immaturity of products and continuous 
innovation hampering purchasing; low levels of 
inter-operability between remote care devices 
discouraging investment and making it difficult to 
establish standards.
Nevertheless, remote care suppliers have major 
ambitions to offer an end-to-end, seamless remote 
care service rather than just providing equipment. 
To move forward, more imaginative approaches are 
needed to change the transactional framework in 
which the demand- and supply-sides operate. New 
forms of supplier-purchaser alliances are required, 
providing an environment in which both the 
demand- and supply-sides grow to their potential. 
Developing the capacity of the remote care industry to supply Britain’s future needs 
Pages 4/5
Professor James Barlow
Professor of Technology and Innovation 
Management, Imperial College Business 
School, and Principal Investigator, HaCIRIC 
There may be lessons from new forms of public-
private partnership, emerging in parts of Europe, 
which are designed to jointly deliver healthcare 
infrastructure and services. These bundle activities 
– health services and infrastructure – to optimise 
outcomes, sharing risk more effectively between 
purchasers and suppliers, and using payment 
mechanisms between parties that incentivise 
appropriate behaviour. 
It will also be necessary to address fragmentation 
on the demand-side. Remote care technologies 
could be a catalyst for new levels of collaborative 
working across health and social care. However, 
the systemic problems of silo-working in health 
and social care could frustrate the comprehensive 
implementation of remote care. Moreover, the 
growing separation between telecare and  
telehealth, both in the narrative around remote 
care and in practice, may continue to reinforce 
fragmented thinking.
Stronger senior leadership will be required to 
construct a shared vision, engaging staff and  
selling remote care within and across health and 
social care services. 
Improved integration will also require better 
understanding of how remote care impacts on 
specific parts of the health and social care system. 
This should help to highlight the potential financial 
disincentives for some stakeholders to implement 
remote care and help inform decisions about how 
to address them.
A better understanding of the system-wide impacts 
would also support the development of business 
cases and business models for remote care. It is 
therefore important to continue the collection of 
robust evidence on the implications of remote care. 
Sir Ian Carruthers’ 2011 review of NHS innovation 
adoption argued for a tariff for telehealth and 
telecare. This needs to be developed. It is also 
important to consider the longer term implications 
on the income of hospital trusts of scaled-up 
remote care.
There is market potential for greatly expanded 
remote care in the UK, which should benefit 
suppliers. The age and morbidity characteristics 
of the population will attract new companies into 
the arena, encouraging innovation and improving 
competition in the industry. There may also be 
untapped potential through a market for ‘elective’ – 
individually paid for – remote care. 
But there is also a danger that current momentum 
will be lost and insufficient investment will be 
made to make the most of opportunities, due to 
weaknesses in the current market.
If Britain succeeds in engineering an environment 
for widespread adoption of remote care, the skills, 
expertise and knowledge could be a valuable, 
exportable good.
www.haciric.org
Introduction
It is certain that, in the coming years, the health and social care needs of 
Britain’s population will be increasingly delivered within their homes with the 
support of systems enabled by information and communications technology or 
ICT. Such ‘remote care’ systems are already with us and are commonly called  
‘telehealth’ – when monitoring an individual’s vital signs – and ‘telecare’ – 
when monitoring an individual’s mobility and general safety in the home  
(see Annex 1 for more thorough definitions).
Care of this type has been around for many years, 
in increasingly sophisticated forms. In the UK, the 
origins go back to the 1970s with the creation of 
the ‘community alarms’ services providing elderly 
people with devices to alert social carers in the 
event of a fall in the home. Today, the possibilities 
have expanded enormously. There is a sense of 
inevitability around the general adoption of remote 
care, which springs partly from such imperatives 
as the ageing population, increasing numbers of 
people with chronic conditions, and constraints 
on the resources available for health and social 
care. The age and chronic health demographics 
are similar worldwide, creating a global market 
opportunity for the industries developing and 
supplying remote care technologies.
The UK’s various publicly-funded programmes 
probably represent the most concerted effort 
by a national government to stimulate remote 
care uptake (see Annex 2 for review of the policy 
background). Remote care is firmly on the agenda 
for future health and social care policy. Since 
1998 there have been more than 25 government 
and other official reports calling for greater use of 
remote care in the UK. At least £160m of public 
funding was spent across the UK on initiatives 
to support uptake over the period 2006-2012. 
The 3millionlives programme1, established in late 
2011, aims to develop the remote care market and 
remove barriers to delivery, with the Department 
of Health and industry working together to bring 
telehealth and telecare to an estimated three million 
people who could most benefit.
The purpose of this report is to consider whether 
the UK is ready to meet this challenge. In particular, 
we are concerned with the supply side of remote 
care and its ability to meet anticipated future needs. 
This is an important, but overlooked, question 
in discussions about remote care, which usually 
concentrate on demand side issues such as the 
fragmentation of the health and social care system, 
funding capacities and possibilities of personal 
budgets to purchase remote care packages. 
Supply and demand are not, of course, unrelated – 
in the UK, development of a coherent ‘market’ for 
remote care products and services will be heavily 
dependent on strong commissioning signals from 
local NHS and social services bodies. 
We are concerned with 
the supply side of remote 
care and its ability to meet 
anticipated future needs.
"
"
1.
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Drawing on extensive interviews with leading 
remote care suppliers and health and social 
care authoritiesi, this report examines the issues 
that should be tackled to gear up the remote 
care industry to meet expected requirements 
for remote care provision. Given the fact that 
telecare (i.e. monitoring an individual’s mobility 
and general safety in the home) is now relatively 
well established, we concentrate more on the 
emergent telehealth sector in this report (i.e. 
monitoring an individual’s vital signs). Annex 1 
provides further definitions of the terminology.
The research was partly funded by Department 
of Health for its evaluation of the Whole System 
Demonstrators (WSD) programme and partly by the 
EPSRC’s Health and Care Infrastructure Research 
and Innovation Centre (HaCIRIC). Box 1 provides 
further details. The views expressed are the 
responsibility of the authors.
In the next section we ask how much remote 
care there is in the UK and where the UK stands 
in relation to other countries. An answer would 
provide a baseline against which to measure 
future performance, and provide an insight into 
the penetration of the concept and extent to 
which this can be leveraged to scale-up these 
services in the future. This turns out to be a hard 
question to answer. 
We then look at the structure of the UK’s remote 
care industry and, drawing on our interviews, 
discuss the perceived challenges to market 
development. Finally, we explore the options 
for addressing these challenges and make 
recommendations for moving forward.
 
Background
The report draws on three related 
research projects carried out between 
2006 and 2011. These have provided 
a large data set which includes over 
250 interviews, over 300 hours of 
observations, as well as documentary 
analysis of material such as meeting 
minutes and reports.
The work reported here includes a 
study partly funded by the Department 
of Health as a contribution to the Whole 
System Demonstrators evaluation 
programme and partly by HaCIRIC 
– the Health and Care Infrastructure 
Research and Innovation Centre.
Supply chain study: methodology
A total of 20 interviews were conducted 
with representatives from leading  
telecare and telehealth technology 
suppliers, national and international, 
and with a range of sizes. We also 
interviewed local health and social care 
authority teams involved in procurement 
decisions in the WSD sites, and a 
remote care expert involved in the 
design of remote care standards and 
best practices. All the interviews were 
carried out during early - mid 2012. 
Data from all interviews were analysed 
using the principles of thematic analysis.  
Additional research involved evaluation 
by an Imperial College Business School 
MBA student of the market research 
reports that were readily accessible 
and publicly available financial data for 
selected remote care companies.
Other source material
The report also draws on various 
related research projects we have 
conducted. Between 2006 and 
2009, we carried out a detailed 
study of five local care authorities 
attempting to implement remote 
care during the timeframe of the 
Preventative Technologies Grant 
(PTG). Subsequently, we became part 
of the evaluation team for the WSD 
programme, where two of the three 
demonstrator sites overlapped with our 
original PTG cases, giving us a five-
year longitudinal data set. In addition, 
between June 2010 and June 2011, 
we were funded by the Department of 
Health to examine the implementation 
of remote care in another six sites.
BOX 1: ABOUT THE RESEARCH
Notes:
i.  To maintain anonymity of interviewees, we 
term these ‘technology suppliers’ and ‘service 
providers’ in this report.
www.haciric.org
What is the market for remote  
care and how big is it?
2.
How large is the current UK remote care ‘market’ – the value of equipment and 
services provided, and the number of users? And how much could it grow?
A number of interviewees felt that there are many 
misconceptions about the potential size of the 
market for remote care. There was concern that 
policy announcements and programmes such as 
3millionlives were inflating the demand for remote 
care technology. 
Market estimations can be made either by 
analysing actual current and projected market 
growth through sales revenue of suppliers or by 
assessing the demand side of the market, i.e. the 
number of actual and potential users. Developing 
a clear understanding of the growth of remote 
care according to either of these variables is 
hard. This is due, in part, to the wide range of 
definitions for telecare and telehealth, uncertainty 
about the number of people who could potentially 
benefit, and the backdrop of changing technology 
capabilities. Estimating the size of the remote care 
market is inevitably an inexact science.
Sales revenues 
Most reports generally focus on the sales revenue 
of technology suppliers and service providers. 
Some include a wide range of mobile medical and 
fitness equipment. There is little consistency in the 
estimates, and projections of market growth are 
usually subject to revision (see Box 2). Estimates 
for the European market size for telehealth in 2014 
range from €165m to €429m depending on the 
definition of telehealth. Companies involved in the 
US home healthcare and disease management 
were said to have earned revenues of $126.8 million 
in 2010; this is expected to reach $294.9 million in 
20152. The compound annual growth rate (CAGR) 
for the global remote care market is thought to 
around 15-20 per cent3 4. In short, there is perceived 
to be an embryonic, but growing, market in different 
parts of the world, but much depends on the 
definition of ‘remote care’ that is used.
Market projections vary considerably and are subject to substantial revision, for example:
•   The market for vital sign sensors is 
expected to double to nearly €300m 
by 2014 (Somsainathan, 2010, Remote 
Patient Monitoring Market in Europe 
Witnessing a High Growth Trajectory.  
Frost & Sullivan.   
www.slideshare.net/FrostandSullivan/
european-remote-patient-monitoring-
market-4751243)
•   Frost & Sullivan’s 2007 estimates for the 
total remote patient monitoring market in 
Europe by 2014 were revised upwards 
in 2010 from €292.3 million to €429 
million. The UK and Germany were the 
two leading countries in terms of market 
revenues in 2009 (Frost & Sullivan, 2007, 
European Remote Patient Monitoring 
Markets and Frost & Sullivan, 2012, 
Consumer-Driven Strategies Prove 
Successful in the Convoluted Remote 
Health Monitoring Market)
•   Datamonitor projections made in 
2007 for the telehealth market by 
2010, including home and hospital-
based telehealth, were later revised 
downwards from €660 million to €323 
million, and from €1,146 million to €425 
million by 2012 (see Baum F, Abadie F 
(2012) Market developments – Remote 
Patient, Monitoring and Treatment, 
Telecare, Fitness/Wellness & mHealth. 
Strategic Intelligence Monitor on Personal 
Health Systems phase 2 (SIMPHS 2). 
Seville: European Commission Joint 
Research Centre, Institute for Prospective 
Technological Studies).
BOX 2: EUROPEAN REMOTE CARE MARKET PROJECTIONS
“Who determines the market? At the moment it is someone  
who said that millions of people can be monitored at home.  
A company looks at that and says ‘this is fantastic, we 
can make a lot of money from this’, so it becomes a self-
perpetuating scenario. And what will happen, if I can make 
a prediction, (with) all these companies coming in with these 
services. I think there will be a lot of really burned fingers in 
3 to 5 years when they suddenly find that the market is not 
there.” (Technology supplier)
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How many users? The potential market size
Another way to estimate the potential market size 
is through the demographic and health profile of 
the population that could potentially benefit from 
remote care. How many of this potential population 
will actually be provided with remote care at any 
given time will be influenced by our understanding 
of which groups of people could most benefit, 
considerations about acceptable risks in supporting 
people in their homes, the economics of providing 
remote care, and the efforts of suppliers to increase 
market penetration. Very broadly, we can group this 
potential market into three categories: 
•  Poorly symptomatic intense users. So far 
telehealth has been used mainly for high risk (and 
high cost) healthcare users, especially people 
with poor symptom management who are intense 
users of health services and have frequent 
monitoring needs. 
    According to one telehealth supplier we 
interviewed, the number of people in this category 
is probably less than generally thought by the 
industry, perhaps 500 to 1000 people per PCTii at 
any given time – a maximum of around 150,000 
in England. Another technology supplier felt that 
the demand from such users could be even lower 
at any given time.
•  There is potentially a much larger market for 
preventative remote care, embracing people 
with moderate needs who are occasional health 
service users. In the UK, the population over 75 
is expected to grow from 4.9m to 8.9m people 
by 2035. In surveys, around 85 per cent of older 
people express a wish to remain at home as long 
as possible5. If a third of these are perceived to 
derive benefit from remote care, today’s potential 
market of 1.4m could grow to over 2.5m over the 
next 25 years or soiii. 
•  The size of the potential UK market for ‘elective’ 
telehealth is unclear. By this we mean telehealth 
services that are privately arranged and paid for 
by individuals for themselves or their relatives. 
Currently, telehealth is a prescribed service 
managed by clinical and social care staff who 
are not keen to manage data and responses 
arising from un-prescribed, individually purchased 
technology. This is because the mere purchase 
of the technology does not take account of 
the services required to support responses to 
it. Whether an elective telehealth market will 
emerge depends on the development of suitable 
business models, greater choice of equipment 
and suppliers, an appropriate supply chain, and 
the integration of the devices into clear care 
pathways. It would also require the population 
to take increased responsibility for its own health 
and be prepared to pay for services that are 
currently free, albeit rationed. 
    Suppliers we interviewed argued that engaging 
end-users more centrally in decisions about 
what telehealth equipment is used could help to 
stimulate awareness and interest, with knock-on 
effects on market development and the design  
of the technology.
Suppliers we interviewed argued that engaging 
end-users more centrally in decisions about 
what telehealth equipment is used could help 
to stimulate awareness and interest, with 
knock-on effects on market development and 
the design of the technology.
Notes:
ii.   The average PCT has a population of 
approximately 284,000.
iii.  A report by the Strategic Society Centre 
found that of the 4.172m people in England 
aged 50 and over in 2007-08, 59 per cent 
live alone and therefore constitute potential 
‘higher-risk, “core” targets for telecare usage’, 
but only 375,000 used personal alarms and 
715,000 used other alerting devices. Lloyd 
J (2012) The Future of Who Uses Telecare. 
Available from www.strategicsociety.org.uk 
“(There) are probably about 150 (high dependency) patients per 
half a million population. High dependency users which go in and 
out of service. That is the market. You are talking 15,900 patients in 
England at any given point in time. These are … people who would 
actually benefit from telehealth immediately and correspondingly 
the health provision side would have the benefit of reducing cost …”
www.haciric.org
How many users? The current market size
So how do these figures for potential 
market size compare with the actual 
number of people receiving remote care  
in the UK? 
Very little is known about how many 
people are receiving different forms of 
remote care at any given time. We have 
tried to estimate the change in the number 
since 2000 from a variety of sources. For 
England we used the annual returns made 
by local authorities to the Care Quality 
Commission (CQC) for the period during 
which the Preventative Technologies 
Grant, a previous Department of Health 
funding programme, was active (2006/07 
– 2009/10). For Scotland we use data 
provided by the Joint Improvement Team 
and, for Wales, the data are based on 
our own research for the Welsh Assembly 
Government6.
The data presented in Figure 1 include 
remote care supplied by local authorities 
and by other private or voluntary sector 
providers. Remote care was carefully 
defined in the CQC data so there was as 
much consistency as possible across local 
authorities and from year to year.  
The data also attempt to ensure that  
the most basic social alarm systems  
are excluded.
Two assumptions have been made in 
our analysis. First, we have included an 
estimate for ‘churn’ – the annual turnover 
of users due to death or because they 
no longer require remote care. From the 
Scottish and Welsh data this appears 
to be around 30 per cent of users per 
annum.  Second, we have estimated the 
number of remote care users for 2000 
and 2005 from our own knowledge of the 
market at this time. Research on telecare 
we carried out at this time suggested that 
there may have been around 5000 users 
in 2000, with around 50 local authorities 
across the UK running small pilot projects 
involving up to 100 users. We have 
assumed this pool grew slowly during the 
early 2000s to reach a total of 15,000 
users at the start of the Preventative 
Technologies Grant programme. 
Our findings are displayed in Figure 1, 
which shows a steady increase in the 
number of remote care users in England, 
Scotland and Wales since the introduction 
Figure 1 
Growth in remote care users 
in UK (Source: see text)
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“Everyone talks a preventative 
agenda. Telehealth and telecare 
work best for a preventative 
agenda, not the top 5 per cent 
(of highly dependent people) 
… The preventative agenda is 
something the government and 
everybody says they want to 
do and then it always gets cut 
when it’s a case of emergency 
care versus preventative care.” 
(Service provider)
“If you’re only going to focus 
on people who have got 
substantial or critical care 
needs and you’re not going to 
focus on people with moderate 
and low-care needs, then you’re 
never going to really embrace 
that preventative agenda and 
build up a long-term benefit in 
terms of reducing the burden on 
the public sector.” (Technology 
supplier)
“The only choice that is 
possible to offer right now is: 
‘Do you want the system that 
our organisation has bought 
or don’t you?” (Remote care 
consultant) 
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of the PTG, reaching around 350,000 
by 2010. This represents perhaps a 
quarter of the potential market, based 
on the assumption that 85 per cent of 
the current 4.9m people over 75 wish 
to remain at home as long as possible5 
and a third of these could benefit from 
remote care at any given time (see 
Figure 2). How many are receiving 
telehealth, rather than more advanced 
forms of telecare other than basic 
social alarm systems, is unclear. One 
report estimates that in the late 2000s, 
out of a possible treatable 450,000 
patients, only about 0.05 per cent – 
22,500 – were receiving a  
telehealth solution7.
Various reports suggest that the 
potential market for both telecare and 
telehealth has some way to grow. For 
example, Frost and Sullivan estimated 
in 2006 that only slightly less than 5 
per cent of all potential end users – 
defined as people over 65 years of 
age – in Europe employ a telecare 
system7. A 2009 study on the use of 
first generation telecare (basic social 
alarm systems) draws a similar picture, 
with the UK and Ireland having the 
highest percentage of people over 65 
using telecare (15 per cent), followed 
by Finland and Sweden (10 per cent)
8
.
The scale of expansion in remote care 
during the late 2000s is perhaps a 
surprising finding, given the general 
perception that the sector remains 
dominated by small-scale trials or  
pilot projects. 
 However, two provisos need to be 
highlighted. While the CQC data are 
most accurate available, they are by 
no means perfect. They are dependent 
on local authorities defining what 
constitutes ‘telecare’ or ‘telehealth’, 
or a remote care ‘installation’, in a 
consistent way. It is known that the 
criteria used by local authorities or 
health trusts to define the number 
of individuals receiving remote care 
variously include homes where sensors 
and equipment are installed, the total 
number of sensors deployed, and 
number of individuals receiving the 
service. Other unknowns are the length 
of time an individual has been receiving 
remote care before it is included in the 
data and the rate of churn within the 
user population. All this makes it very 
hard to accurately gauge how fast and 
extensive take-up has been. 
We also know nothing of the growth 
rate since the CQC data stopped being 
collected in 2009/10. There are signs 
that the expansion may have tailed-off. 
The recent audit of local authorities 
by the Good Governance Institute 
found that ‘despite 1.5 million people 
currently using telecare in England, 
figures reported by councils through 
the audit only accounted for a fraction 
of this’. When asked about use of the 
additional £648 million allocated to 
local authorities by the NHS to support 
social care services in 2011/12, only 
£28m had been spent on telecare and 
43 per cent of PCTs saw no investment 
in telecare9.
Figure 2  
Actual and potential 
remote care market in 
the UK (Source: see text)
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The UK remote care supply industry 
and challenges to market development
3.
“ Unless you start spending some money in the market place then I can see a lot of companies disappearing, particularly in this current 
financial climate, because you can’t carry on with nothing coming through the door. You need cash flow.” (Technology supplier). 
“I think there are a very few challenges in the technology. Technology’s our business. We will come up with new technologies, and 
those technologies will have a role to play. The challenge is in transforming the care from the current model of hospital-centric 
care to a patient-centric, home-based care, and the NHS has a long journey to get there … I think if we can move quicker towards 
an integrated care model, then telehealth has a much greater chance of evolving.” (Technology supplier)
If remote care is to become a key part of future health  
and social care delivery, its supply chain – the relationships 
between the different parties involved in manufacturing 
equipment, providing the underlying infrastructure, and 
delivering the service – will need to become clearer and 
better established. The industry supplying the technical 
infrastructure for mass remote care – its equipment and 
associated services – is a key component of this supply 
chain. But the extent to which the industry is ready to 
meet the challenges in scaling-up from the existing 
position is little discussed. 
A growing view amongst suppliers we interviewed is that 
the market is trapped in a vicious circle. Uncertainty about 
demand leads to unwillingness to commit to investment 
both in the development of new technologies and in the 
allocation of care service budgets to remote care.
From the perspective of suppliers, many of the barriers 
to market expansion are perceived to be due to a mix 
of demand side factors. However, they also accept that 
there are a number of problems with supply side industry 
itself, notably around industry structure.
Problems with the demand side 
Fragmentation and silo-based behaviour in healthcare
Suppliers are particularly concerned about the 
fragmentation of remote care purchasing, particularly in 
the NHS, which makes it difficult for them to negotiate 
and deliver substantial projects. In particular, there is a 
lack of clarity within health services about who should 
be responsible for telehealth. The incentives for different 
stakeholders to adopt remote care have yet to be 
resolved. There remains confusion about who pays for 
what, and no clear demarcation between health and social 
care over responsibilities for services for those with long-
term conditions. This is compounded by turbulence in the 
NHS structure created by the current reform process. 
Suppliers had mixed views on the impact of the latest 
round of reforms and devolution of spending decisions to 
a much larger number of Clinical Commissioning Groups 
(CCGs) than the PCTs they are replacing. Suppliers 
expected this to increase the level of organisational 
fragmentation, although they anticipated that the change 
to GP-led CCGs may increase opportunities for them to 
play a more active role in providing end-to-end services. 
But they also argued that a lack of interest by many GPs 
– due to limited awareness of telehealth or concerns that 
monitoring and response would increase their workload 
– would ‘close down’ the embryonic market. Suppliers 
hoped that there would be sufficient telehealth already 
‘on the ground’ and embedded before CCGs became 
established, but this was seen as unlikely.  
Lack of integration and joined-up thinking across 
health and social care services.
Suppliers felt that the flow of information, cash and 
resources across boundaries in health and social care 
continues to be a significant barrier to investment. There 
is often a confusion of interests among the multiplicity of 
stakeholders both within and between health and social 
care. Acute hospital stakeholders may see potentially 
lower costs resulting, for example, from reductions in 
demand for in-patient beds. Others, such as social 
services departments, may be net cost-bearers as more 
people remain at home.  So, even if convincing evidence 
about potential positive economic benefits arising from 
reduced demand on acute care is gathered, new thinking 
is needed to ensure that every stakeholder is incentivised 
to implement the change.
“(GPs) will be looking for evidence. I think there’ll 
be some groups which will be very strong supporters 
based on the evidence, others who will just not be. 
I think it’s going to be a mixed bag ... GPs typically 
have three reactions, enthusiast, sceptics and 
indifferent. And I think that will be the same in 
commissioning groups.” (Service provider)
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Problems of leadership and culture 
Management in the NHS is not strong 
enough to overcome apathy and general 
resistance to change and drive or impose 
developments required to accommodate 
remote care services. There are leadership 
difficulties in delivering such a major 
service change at any time, but especially 
during a period of NHS reform, financial 
cutbacks, constantly moving workforces 
and shifting organisational priorities. And 
some suppliers felt that there was no real 
culture of innovation within the NHS bodies 
they engaged with, partly because of their 
monopoly position in providing healthcare. 
Too many pilot projects
The lack of leadership and the structure 
of health and social care provision, 
with considerable local autonomy, can 
lead to repeated pilot projects that are 
neither sustainable nor scalable. This 
results in duplication of effort and lack of 
standardisation nationally. Our research 
has found that the creation, through 
pilot projects, of small pockets of activity 
and excellence can be divisive, even in 
cases with a long history of ‘joined up’ 
working across acute, primary and social 
care services. This results in issues of 
ownership of remote care projects that push 
people apart rather than together10 11 12 13. 
Additionally, small-scale pilot projects in 
remote care have limited usefulness when 
developing lessons for scaling-up services. 
Issues ‘resolved’ in such pilot projects 
often do not translate when attempting to 
implement remote care more widely14 15.
Procurement is poorly developed
Two concerns relating to procurement of 
technology were identified by suppliers. 
First, suppliers believe that care 
organisations often do not have the level 
of organisational capability and capacity 
to act as ‘smart purchasers’, with a clear 
understanding of their own needs and 
consistent models for procuring technology, 
particularly telehealth. Collaboration with 
suppliers and other experts is therefore 
essential for developing a mainstreamed 
and sustainable remote care service. 
However, maintaining collaborative 
relationships with a highly fragmented NHS 
is costly and unrewarding.  
Moreover, fragmentation on the demand 
side means that care service providers do 
not have strong enough market muscle. 
The NHS as a whole has not used its buyer 
power sufficiently to drive the procurement 
agenda because multiple organisations are 
buying in small quantities, individually. There 
is concern that this problem may get worse 
following introduction of a large number of 
CCGs.
Secondly, suppliers are critical of the 
Buying Solutions Framework Agreement, 
a centralised remote care procurement 
route for public sector organisations. 
While this is seen by health and social 
care organisations as a useful way of 
checking product availability and pricing, 
suppliers suggested that inclusion on the 
framework is partly a matter of ‘ticking the 
right boxes’. Low inclusion criteria do little 
to encourage the competition essential 
for the development of a dynamic industry 
and healthy marketplace. Suppliers also 
argued that the framework encourages the 
view amongst NHS buyers that telehealth 
systems are simply ‘devices’. Tender 
documents are often simply a list of desired 
products, with little understanding of the 
way these needed to be integrated into a 
service model.
“The commissioner says it is a provider 
issue but the provider says the 
commissioner gains because the people 
don’t go to the hospital. Hospitals won’t 
pay because they get income from people 
who get admitted, so the whole thing 
is broken with the way it is set up.” 
(Technology supplier)
“I’m hoping with the latest White Paper, 
and once things begin to sort themselves 
out, that there will be a joined up 
approach. Because at the moment there’s 
no incentive to keep the patient out of 
hospital.” (Technology supplier)
“There is no external pressure on the 
NHS to adopt innovation, whereas in a 
competitive environment you want to 
stay one step ahead of your competition, 
therefore you’ll find competitive advantage 
through innovation. You either compete 
on price or on the innovation. But in the 
NHS they compete on neither as there is  
no competition.”  
(Technology supplier) 
“There’s more that could be done to say 
‘we expect these standards to be introduced 
within a given time frame’, so when you 
set contracts today people are committed 
to actually achieving levels of functionality 
in the future that meet the central goals.” 
(Remote care consultant)
“You just buy some devices and away 
you go. But in reality, people (should be) 
buying a system, and whereas the device 
that they bought may have a life of three 
years, the software, the skills, the training, 
the organisational knowledge of it would 
probably stick around for ten to fifteen. But 
people weren’t buying stuff with that in 
mind.” (Technology supplier)
“We’ve got 76 primary care organisations 
that have got a telehealth solution in 
one shape or size. Typically, the vast, 
vast majority of them exhibit a similar 
characteristic, which is that they are 
below 15 patients, and that’s because they 
tend to be sponsored by one local team 
of  clinicians, they get some funding, and 
they achieve great things, but, effectively, 
those clinicians are running two clinical 
pathways. They’re running a pathway 
for patients who don’t have telehealth, 
which is the conventional clinical pathway, 
and they have to run a separate bespoke 
pathway which they engineer on a locality 
basis to accommodate this technology 
that they’re using in a pilot. So it’s not a 
long-term and sustainable pathway. It’s a 
temporary accommodation for a project.” 
(Technology supplier)
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3. The UK remote care supply industry and challenges to market development (continued)
There are also problems on the supply side 
The current remote care industry in the UK comprises 
an ecosystem of different companies and organisations 
providing hardware and services. As well as the suppliers 
of home hubs and peripheral devices such as sensors, 
there is a diverse range of other companies involved in 
various segments of the remote care market:
•  Telecare alarms and sensors for use in the home 
environment, largely purchased by social care 
authorities.
•  Telehealth monitoring devices for use in the home 
environment, purchased and used by local health trusts 
•  Monitoring centres, responsible for receiving and 
responding to telecare (and sometimes telehealth) data
•  Telecommunication operators (both the traditional 
networks and mobile operators) which enable the 
transmission of patient readings and subsequent 
feedback. These could be responsible for the 
management of a large volume of secure data traffic if 
remote care reaches its potential. 
There was an acceptance amongst our interviewees that 
some of the challenges in scaling-up remote care will 
spring  from the current structure of the supply industry. 
The key points from the interviews are:
The industry remains small-scale and fragmented
While large players are becoming increasingly involved 
in the UK, the typical firm is small. The core device 
manufacturing sector is concentrated in South East 
England, where there were 47 companies generating 
more than £550 million in sales and employing around 
2000 people in 200916, suggesting that the typical 
company is  an £11m turnover, 40-person business. The 
most recently reported global turnover of the UK’s largest 
remote care supplier, Tunstall, was £190m. A trend 
towards mergers and acquisitions within the industry 
seems likely – Tunstall has acquired American Medical 
Alert Corp (AMAC) and STT Condigi. In general, though, 
the UK sector is dwarfed by the larger global players. 
For example, Philips’ home healthcare division (which 
includes a range of products as well as telehealth) had 
an annual global turnover of €1.2bn in 2010, including 
€285m in Western Europe.
No single player has all the capabilities to provide an 
integrated remote care service, so partnerships will be 
needed to bring solutions to market.
Future business models will therefore be shaped by the 
particular configurations of partners and their different 
roles within the overall remote care value chain. A 
company could be active in several, even all, areas 
such as hardware supply and service delivery, as well as 
telecare and telehealth.
It is still hard to identify suitable  
business models.
The key features of a successful business model are an 
identified market, a value chain to create and distribute 
the offer, an understanding of the value chain’s cost 
structure and profit potential, and understanding of the 
roles of different suppliers in the value chain, and finally –  
for private sector companies – a competitive strategy to 
gain and hold advantage over rivals. 
In remote care in the UK, these features are only partially 
developed. There are many narratives for the remote care 
‘story’ – it is about prevention, risk management and 
supporting independence.   
And the technology is variously described as ‘telecare’, 
‘telehealth’, ‘telemonitoring’, ‘telemedicine’, ‘assistive 
technology’, ‘telehealthcare’ and sometimes ‘smart 
homes’. The imprecise terminology allows many different 
industry players to describe themselves as being part of 
the market for remote care technology, but it also makes 
it hard to clearly describe the ‘customers’ for remote care, 
what they value, and how money is made. 
“The telehealth market is, despite what some 
vendors would say, wide open. There’s no definite 
market leader or market leading product ... There 
are about 50 or 60 different implementations 
around the country. We know that all but about 
five of those are less than 50 (patients), so it’s 
very, very small, very isolated. It’s very ‘early days 
entrepreneurial’ in terms of what they’re talking 
about and now a few people are moving to scale.” 
(Remote care expert)
“With very few exceptions the telehealth market is 
at an embryonic stage in the UK.”
(Technology supplier)
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Another fundamental problem in the development of 
remote care business models has been the absence of 
definitive evidence for its benefits. From the perspective 
of a health or social care organisation, a lack of evidence 
makes it hard to develop a business case for investment; 
for suppliers business models remain hard to pin-down 
because it is unclear what the value proposition is or  
how to price it. 
The cost of remote care services was frequently raised 
not only as a barrier to adoption but also in relation to 
the evolution of a remote care industry and market. 
Competition amongst technology suppliers has 
emphasised technology development but also the cost of 
solutions to service providers. The challenge for suppliers 
is how to balance a ‘one size fits all’ approach – with 
sufficient adaptability to respond to future patient needs 
and expectations – and a mass-customised model 
designed around the specific needs of end-users but 
using  standardised components.
Who bears the cost of equipment and services – whether 
‘one size fits all’ or more customised – is, of course, a 
crucial factor in business models, and one that is related 
to the prevailing payment and reimbursement models and 
eligibility criteria for remote care. The problem is that these 
have yet to be developed (in the case of NHS provided 
telehealth) or they vary according to local circumstances 
and priorities (in the case of local authorities and telecare). 
Although policy emphasises the importance of prevention 
and earlier intervention across health and social care, local 
authorities do not have sufficient resources to provide 
telecare to both critical and lower needs populations, 
hence most prioritise the former. And for telehealth, the 
discussion about eligibility and payment models has not 
even begun.
The immaturity of products and continuous innovation 
adds to supply side complexity.
It was noted how competition essentially emphasised 
product development and technical solutions, meaning 
that, from an end-user point of view, the market looks 
complex and unstable. As one technology supplier put it:
There remain significant problems with interoperability, 
information exchange and ‘technology lock-in’.
Re-procurement of remote care technology is estimated to 
be necessary every three and five years, when equipment 
reaches the end of its lifecycle. However, service providers 
argued that it is not easy to change suppliers. This is 
partly due to interoperability issues and the low levels of 
co-functionality that exist amongst remote care devices. 
Changing the equipment can mean changing the whole 
infrastructure at great expense. Service providers argued 
that staying with the same supplier might therefore be a 
better option, both for cost reasons and to build a sense of 
stability and continuity for end-users. 
Interoperability also has implications for the fragmentation 
of care services. While there is emphasis in policy and 
research on the integration of services, supply side 
interviewees felt that the inability of social and health 
services to exchange would ensure that dreams of ‘whole 
system working’ remain dreams.
Prospects for the industry to come together to decide on 
standards and interoperability issues were felt to be higher 
within rather than across the health and social care silos. 
In the immediate future, suppliers argued that the Buying 
Solutions framework agreement should be reformulated 
to ensure that interoperability standards are built into the 
procurement model. In the longer term, there was hope 
from both suppliers and service providers that an open 
source platform would be developed, enabling devices to 
be mixed and matched. This was felt to be essential for 
the growth of a self-pay ‘elective’ remote care market.
‘There’s not enough evidence, which is why so many people are waiting 
for the results of the national trial. And then I think you’ll find that the 
marketplace will take off, providing the results come back in a positive 
way. And if they don’t come back in a positive way or they’re inconclusive 
I think that will really hinder the market.” (Service provider) 
“(It’s) very difficult to get people to invest because the evidence base 
is very limited. There is evidence but even when there’s evidence, the 
clinical profession, who only ever work on evidence based activity, still 
can’t quite get over that hump of ‘well it is evidence and it does work but 
I’m not sure if I want to risk it’.” (Service provider)
“We saw a telecare group moving across to telehealth, not in terms 
of what they could do but just realising that there is another market 
which is beginning to do better. And I think that has been a bit of a 
mistake. I think we lost the focus somewhere and some people would 
prefer to call it all ‘telecare’, but it is not telecare and telehealth 
(means) a different thing. I prefer ‘remote care’ myself or ‘hospital 
without wards’. “(Technology supplier)
“It has to do with the innovation life cycle. None 
of the real telehealth and telecare providers has a 
mature product, so they are still creating innovation 
to capture market share. Currently it seems that 
forever they will release a new product or new 
features, making it difficult for the end users.” 
“I think people were always a little bit shy and didn’t (discuss 
economics)… you know, talking about the patient, and it is all about 
the patient. Whilst it is all about the patient, there is a place for the 
economics … it’s only been in the last six months where people have 
been open about that.” (Technology supplier)
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Notes:
iv.   The system, applying to all local authorities 
in England, for ensuring fair and consistent 
decisions about how much support people 
with social care needs can expect.
3. The UK remote care supply industry and challenges to market development (continued)
The ambitions of the supply side
Despite the current challenges faced by remote care 
suppliers, they have major ambitions for the future, 
referring to the five ‘Rs’ of remote care – the ability to 
provide the ‘right approach at the right time for the right 
cost for the right reasons in the right place’. The majority 
also aspire to offer a more integrated service rather than 
just providing equipment. Interviewees unanimously 
referred to their goal of becoming a ‘solution provider’, 
arguing that they have the capacity to provide an end-to-
end seamless remote care service. This would allow them 
to gain greater control over telecare and telehealth value 
chains, with the supply of equipment being a smaller part 
of their offer. 
Suppliers argued they were beginning to feel more 
confident that they have developed the capabilities 
to do this. So far, developing a more holistic role has 
involved helping health and social care providers not only 
with technical and operational issues such as training, 
installation and repair, but also with support on the 
development of business cases – drawing on their own 
studies of remote care effectiveness – and on service 
redesign around remote care. 
But a wider role in service provision might see suppliers 
moving into and consolidating the monitoring and call 
centre sector, with a set of standardised processes and 
agreed code of practice. This was felt to be more likely to 
happen with telehealth than telecare, given the embryonic 
state of the former and lack of knowledge within health 
trusts about how to use the technology to its full potential. 
There was general agreement amongst the suppliers 
that in the longer term there will be an increased role in 
telehealth services for the private sector. A quasi-private 
telecare model already operates for those who do not 
meet the Fair Access to Careiv criteria, and growth in 
self-funding models is seen as a possible direction for 
telehealth. This, of course, raises fundamental questions 
about the nature of NHS provision and attitudes from 
health and social care providers were often at odds with 
this ambition. 
*    *    * 
There are clearly problems of structure, evidence and 
business development that the supply side itself needs to 
address if it is to grow to an appropriate size to both meet 
its own ambitions and cope with the planned growth of 
remote care. Suppliers argue that they have the capacity 
and ambition to do a great deal more than  
the demand side currently seems willing  
to require. 
But poor supply side development appears, to a 
considerable extent, to be an economically rational 
response to uncertainty in demand for remote care. 
If demand is a major problem for stimulating supply, 
how do we transform the transactional framework to 
create change and achieve what is the ambition of both 
government and the supply side?
“We’re stuck with the equipment we’ve got...but we can, dependent on 
budget, purchase certain other equipment.” (Service provider)
“If we change the supplier, as it stands we’d have to change pretty 
much everything. So we’d have a huge job on our hands. It’s not 
interchangeable ... the devices in the patient’s home wouldn’t therefore 
work with the software back in the base, so it’ll be a big issue.”  
(Service provider)
“All the kit that’s installed is developed by (company name). You can’t 
feasibly mix and match telecare equipment …  Every now and again it 
improves and then there’s another advance and there’s lock down again 
… and it goes around in circles.” (Service provider)
“I personally don’t like the telehealth private sector 
providers who want to run the telehealth service for 
me … Why am I employed if somebody is going to 
run the thing for me?” (Service provider)
“The role of the private sector depends on the cost. 
You might get an organisation coming in that says 
they can provide the service. I don’t think they’d be 
able to do it with the same expertise and as cost 
effectively as we could, so we would fight them tooth 
and nail.” (Service provider)
“They don’t provide the service, they provide the 
tools.” (Service provider) 
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care will require more than 
is currently proposed under 
government policy.
"
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Options for transforming  
the remote care market 
4.
More centralised spending on  
remote care? 
In principle, a more dirigiste, centrally-controlled approach 
on the demand side could tackle many of the issues we 
have outlined. It would result, for example, in clear and 
predictable levels of demand, against which the supply 
side could plan and grow. It could also create a forum in 
which might be generated the missing cost-effectiveness 
data about remote care, and so reassure and inform the 
future spending decisions of healthcare organisations. 
This could create the conditions in which the supply side, 
particularly in telehealth, might grow in size and make the 
transition from manufacturing to service provision.
However, the localist philosophy that underpins current 
NHS policy would seem to rule out the widespread 
introduction of remote care by writ. And there are many 
concerns about the extent to which even large pilots such 
as those under the DALLAS – Delivering Assisted Living 
Lifestyles at Scale – programme can result in eventual 
widespread adoption of remote care. It seems clear that 
the government would prefer the functioning of a more 
spontaneous market. Therefore, we need a proposal that 
might stimulate development of such a market.
Merging the provision of health  
and social care? 
The historic divisions between health and social care 
continue to make it difficult to reduce the number 
and diversity of interests on the demand side. Closer 
integration between health and social care would not 
eliminate silo-working but it would make matters easier, 
reducing the numbers of stakeholders and problems 
related to cost-shifting between the two systems. 
However, such a transformation, although an historic 
panacea for many policy-makers, seems unlikely to  
occur soon.
Any other options? 
If the remote market can be steered by central 
government only to a limited extent, and bureaucratic 
divisions cannot simply be removed by institutional 
reform, what is to be done to push health and social care 
provision in the direction that so many see as necessary?
In the absence of radical change, remote care advocates 
will need to create a sophisticated evidence base and 
a framework for mutual collaboration that incentivises 
the multiplicity of stakeholders all to move in the same 
direction. Once different commissioners have engineered 
shared objectives and visions, a substantial market could 
effectively have been created for remote care, allowing the 
supply capacity to grow. How is this to be achieved? We 
suggest a possible way forward.
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“  It does not matter how much effort you put into relationships 
building and whether you bend over backwards to satisfy 
them. They will dump you if someone new comes along.”
A new type of partnership  
for remote care 
The current imperfections in the market for remote care 
have resulted in a vicious circle, leading to sluggish 
demand and supply sides each inhibiting one another. 
This suggests a need for new institutional relationships 
that bring the two sides together more effectively, creating 
a close dialogue that stimulates each and creates a 
virtuous circle.
The importance of better partnerships was supported by 
our interviewees. Suppliers complained that a ‘partnering 
philosophy’ is lacking in the public sector (even though 
technical interoperability problems described above 
ensure that suppliers and customers are tied together for 
the medium term at least). Relationships were perceived 
as time consuming and labour intensive because of 
the fragmentation of local approaches to payment 
and reimbursement or eligibility criteria, and levels of 
experience or understanding. Much time was spent on 
trying to maintain the interest of potential customers. 
According to one technology supplier,
Suppliers argued for a move from supply chain 
relationships that were purely transactional towards 
ones that involved closer collaboration and knowledge 
sharing. They would like strategic supplier-purchaser 
alliances, with contracts reviewed periodically to address 
changing demands, new market development and 
performance. This was seen as a way of helping to 
identify innovative new models for remote care, and 
increasing their organisational capabilities and competitive 
advantage. The benefits of such an approach could be 
simultaneously to generate greater confidence in remote 
care on the demand side, while increasing certainty of 
income generation to remote care suppliers. 
There are encouraging signs that were this more trusting 
environment to be engineered, suppliers would respond 
creatively and effectively. Suppliers involved in the WSD 
programme emphasised that it helped build closer 
relationships with service providers, going beyond that of 
subcontractor and facilitating shared learning and the joint 
development of operating principles.
A move towards strategic supplier-purchaser alliances 
was felt to be increasingly necessary as remote care 
began to develop in its scale and scope. Suppliers 
and service providers both agreed that, with more 
sophisticated forms of telehealth and telecare, the ability 
to retain greater control over service quality and supply 
chain performance would become more challenging. 
Greater supply chain complexity could be managed 
providing purchasers (i.e. health and social care  
providers) have:
•  the capabilities to make clear strategic decisions from 
the outset, with a well-defined and agreed vision about 
their objectives and requirements
•  there is regular control over supply chain  
performance, and 
•  there is open communication between all the partners
There is no obvious ideal model, but elements of 
public-private partnerships (PPP) that are designed to 
jointly deliver healthcare infrastructure and services, 
which are emerging in parts of Europe may offer some 
lessons. These PPP agreements are more all embracing 
than the traditional UK PFI model, which only covers 
infrastructure and non-clinical services17. They bundle 
together activities – health services and infrastructure 
planning and delivery – to optimise outcomes, sharing 
risk more effectively between purchasers and suppliers, 
and using payment mechanisms between parties that 
incentivize appropriate behaviour. The Local Investment 
Finance Trust (LIFT) programme in England offers another 
example, where its projects brought together private 
contractors, local authorities and Primary Care Trusts into 
long-term partnerships to develop health and social care 
infrastructure.
These types of PPP might provide greater certainty of 
income for remote care suppliers while removing some 
of the risk to the public sector, which make it averse to 
investing in remote care.
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4. Options for transforming the remote care market (continued)
Recommendations
‘Scaling-up’ is not necessarily the same as ‘growing large’ 
– it’s about normalizing practices, embedding them into, 
and changing, existing models, and in doing so,  
expanding impact18. 
Constructing a shared vision of a remote care future will 
play an important part in creating the right institutional 
arrangements – ones with legitimacy across all 
stakeholder groups – for scaling-up remote care. As yet, 
that vision remains somewhat opaque, with rather limited 
understanding about the role of remote care in future 
health and social care models. A clearer vision should 
begin to emerge as better evidence about what works, 
when and where, is gathered. But to deliver that vision  
will require that certain limitations in the current care 
system should be addressed.
Many of these recommendations require detailed attention 
by policy makers, who now need to shift attention from 
looking at ‘big solutions’ to cope with emerging pressures 
on health and social care to the pragmatic changes that 
need to be put in place to facilitate greater adoption of 
remote care. 
Leadership 
Practical operational tasks such as training staff on how 
to do referrals and use the technology are insufficient to 
build the necessary shared language and vision to push 
large scale remote care implementation forward. Constant 
and sustained attention needs to be paid to the job of 
winning hearts and minds and maintaining commitment 
and momentum. That is easier if a cogent and ‘joined up’ 
approach to remote care is developed from inception. 
But achieving redesign of services around remote care 
will require organisations to be open to change and to 
embrace a culture that is prepared to experiment, allow 
for mistakes and collectively learn from them.
Strong senior leadership is key to constructing a 
shared vision, engaging staff and selling remote 
care to an organisation-wide audience, and for 
legitimising any increased risks and resources 
involved in scaling-up remote care.
Addressing fragmentation  
on the demand side 
Developing remote care services on a larger scale 
requires new levels of integration between different 
care organisations, refocused beyond individual patient 
benefits to the wider system benefits such as reduced 
unplanned hospital and care home admissions.
Remote care technologies could be a catalyst for new 
levels of collaborative working across health and social 
care. It will, however, be vital to ensure that the opposite 
does not occur – the systemic problems of silo-working in 
health and social care could frustrate the comprehensive 
implementation of remote care. Nor is the growing 
separation between telecare and telehealth, 
both in the narrative around remote care and in 
practice, helpful because it will continue to reinforce 
fragmented thinking. 
Developing new strategic partnership models will have to 
overcome lack of trust across organisational boundaries 
as well as the current fragmentation and duplication of 
processes, with different organisations following different 
protocols. 
A better understanding of how the costs and benefits of 
remote care are spread across stakeholders in different 
parts of health and social care would help by highlighting 
the financial disincentives for some stakeholders to 
implement remote care and helping decisions about how 
to address them. 
“If you leave change to local authority or NHS 
nothing is likely to happen. Saying that clinicians 
are much more interested in innovation if you 
show them clinical evidence (is not enough) ... 
They will think it is a good idea, not that it needs 
to be adopted.” (Technology supplier)
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Business model development 
New business models for remote care will have to deliver 
a return on investment that is acceptable to the different 
stakeholders from both the demand and supply sides. It 
is therefore important to continue the collection of robust 
evidence in order to demonstrate to service users, as 
well as to the health and social care professionals and 
purchasers who influence service configuration, whether 
remote care is a ‘must-have’. 
But, even if the economics are shown to be compelling 
at a macro-level, we must understand better how 
remote care impacts both positively and negatively on 
specific parts of the health and social care system, and 
over different timescales. Greater use of simulation and 
modelling could help to harness the emerging evidence 
base to this end by highlighting the potential impact of 
remote care across the care system, over time and  
under different assumptions about the speed and scale  
of implementation.
In the immediate future, business models for the  
provision of remote care within the NHS and social 
services-led care systems are needed. In the longer-term, 
though, there may be untapped potential in the market 
for ‘elective’ rather than ‘prescriptive’ remote care. Since 
this market exists outside NHS provision, it may be easier 
for suppliers to access. The development of personal 
budgets and direct payments is a key social  
care policy objective for the government, which may, in 
time, give individuals greater influence over their remote 
care provision19.
Disincentives in the NHS tariff 
Remote care may have implications for the NHS tariff. 
At present, healthcare providers are paid according to 
a tariff system based on the average cost of a group 
of procedures. This is based on current practice and 
would not subsidise the extra, short term cost of 
introducing remote care, even if it improved the quality 
and effectiveness of care over time. This was recognised 
in Sir Ian Carruthers’ review of NHS innovation adoption20, 
which states that financial, operational and performance 
incentives to support the adoption and diffusion of 
innovation will be aligned and, in particular, a tariff for 
telehealth and telecare will be developed. This is to 
be welcomed. It will, however, also be important to 
consider the implications on the income of hospital 
trusts of scaled up remote care – if it improves 
efficiency by reducing activity, an NHS provider could 
expect to be penalised because its income would be 
reduced under the tariff system. 
Who are the clients of remote care? 
If the identification of individuals who can most benefit 
from remote care is to improve, it will have to be easier 
for health and social care professionals to ‘prescribe’ it. 
This will require greater awareness of the technology’s 
potential in relation to an individual’s evolving needs. The 
availability of a shared health and social care record 
keeping service and electronic national ‘single 
assessment process’ could help. However, progress 
has been disappointing, with data sharing among NHS 
staff remaining poor, and unlikely to be easier if social and 
community services are also involved. 
Supporting the remote care industry? 
Some interviewees highlighted the lack of government 
support for UK-based SMEs developing remote care 
products, which were perceived to be highly innovative 
but facing an uphill struggle in both moving from the 
prototype stage to larger trials and also in marketing their 
products in a highly fragmented system. Better financial 
support to address the former was seen as essential and 
there were calls to find ways of encouraging PCTs and 
local authorities to ‘buy British’. It was also suggested that 
telehealth products should be treated as medical devices 
to tackle perceived competition from low cost products 
from foreign suppliers which have not been through the 
same quality assessment checks as UK devices. 
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Policy makers need 
to shift attention 
from ‘big solutions’ 
to pragmatic changes 
which can facilitate 
remote care adoption.
"
"
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5.  Conclusions
There are many positive factors which should support future development of the UK’s remote 
care industry. There is government support through policy backing and funding. Remote care is a 
significant research area, creating a potential pipeline of superior next generation technology. The UK 
also has considerable expertise in research on its impact and implementation challenges. There are 
organisations geared towards promoting the uptake of remote care technology, such as the Telecare 
Services Association and the South East Health Technology Alliance (SEHTA), as well as various 
knowledge transfer networks.
There is market potential for greatly expanded remote care, which should benefit suppliers. The age 
and morbidity characteristics of the population will attract new companies into the arena, encouraging 
innovation and improving competition in the industry. There may also be untapped potential through a 
market for ‘elective’ – individually paid for – remote care. 
But there is also a danger that current momentum will be lost and insufficient investment will be made 
to make the most of opportunities due to weaknesses in the current market. Current schemes are 
generally small-scale and lack coherence. There could be continued ‘pilot-itis’, with lessons learnt 
from pilot projects not disseminated sufficiently or accepted locally, resulting in duplication of effort 
and lack of standardisation nationally. Procurement of equipment and services is complicated and 
fragmented. Critically, delivery of remote care at scale requires a degree of integration across multiple 
stakeholders from the private and public sectors. Payment and reimbursement models, along with 
eligibility criteria under the NHS, remain to be developed.
It is hard to escape concluding that the widespread adoption of remote care will require more than 
is currently proposed under government policy. Our report suggests options for more imaginative 
approaches which would change the transactional framework in which the demand and supply sides 
operate. Some new form of partnership is required, providing the environment in which both the 
demand and supply sides are catalysed and can grow to their potential. 
The healthcare economy that succeeds in creating such an environment and engineering this 
transformation will develop skills, expertise and knowledge that can be exported across the world.
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Annex 1  
What do we mean by ‘remote care’? 
6.
Remote care involves the delivery of 
health and social care to individuals 
within the home or the wider 
community with the support of ICT 
enabled systems. Many terms are 
used interchangeably to describe 
remote care
v
 such as:
• ‘Telecare’
• ‘Telehealth’
• ‘Telehealthcare’
• ‘Telemonitoring’ 
• ‘Telemedicine’
• ‘Assistive technology’
• ‘Smart homes’
In this report we focus on aspects 
of remote care which relate to the 
delivery of two types of service 
– ‘telehealth’ (i.e. monitoring an 
individual’s vital signs) and ‘telecare’ 
(i.e. monitoring an individual’s 
mobility and general safety in the 
home). Currently, monitoring in 
both cases is usually in people’s 
homes, although there is no reason 
to suppose that, as the technology 
develops, remote care cannot 
be extended to the workplace or 
anywhere an individual moves. 
A distinction is usually made 
between telecare and telehealth 
because in the UK – as in other 
countries – responsibility for providing 
health and social care remain 
split between different agencies. 
Currently, telecare is essentially a 
safety net for vulnerable people, a 
responsive service whereby social 
services intervene when a problem 
is detected. However, in time, it 
could evolve into a more preventative 
model, where trends in a vulnerable 
individual’s activities of daily living are 
used to detect the onset of increased 
care needs.
Telehealth is essentially a trend 
management service, allowing 
patients and care staff to manage 
particular long-term conditions. 
Clinical knowledge is required, the 
relationship between the individual 
and health service is arguably 
more pro-active than reactive, and 
patients have an active role in their 
self-management. It therefore has a 
potentially vital role in the creation of 
more preventative healthcare. 
We also need to draw a distinction 
between telecare / telehealth and 
‘telemedicine’ (see table below). 
Telemedicine typically involves 
consultation with a doctor or 
specialist, at a distance, about a 
specific condition, for the purposes 
of diagnosis or referral. The relative 
simplicity of telemedicine compared 
with telehealth – an inherently more 
complex system to set up, involving 
monitoring people in their own 
homes, multiple organizations and 
complex informational and financial 
relationships – probably explains why 
telemedicine is now more widespread 
around the world.
Key characteristics of telecare and telemedicine
Telemedicine
Aimed at diagnosis or referral, usually focusing on 
specific conditions 
Lots of ‘tele-ologies’  
(e.g. teledermatology, teleradiology)
Can work in real time or on a store and forward basis
Essentially a B2B model (i.e. between health 
professionals, possibly with the patient present)
Few stakeholders, so relatively easy to implement
Telecare
Brings care directly to the end-user generally in a  
non-institutional setting
Focus on monitoring for prevention or safety and 
security, or advice and support
Can work in real time or on a store and forward basis
Essentially a B2C model (patient centred, and  
always present)
Many stakeholders, so far more complex and  
inherently harder to implement
Notes:
v.  For a good discussion on  
terminology see  
www.telecareaware.com/index.php/
what-is-telecare.html
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Annex 2  
The policy background 
7.
Since 1998, there have been at 
least 25 government and other 
official reports calling for greater 
use of remote care in the UK. At 
least £160m of public funding was 
spent across the UK on initiatives 
to support uptake over the period 
2006-2012. 
The largest initiatives have been 
in England, starting with the 
Preventative Technologies Grant 
(PTG) during 2006-8. This was 
an £80m programme to provide 
all social care authorities with 
funds to invest in telecare so that 
160,000 older people could ‘remain 
independent at home’21. The PTG 
was positioned as a catalyst for 
change, giving local service providers 
in England the push they needed to 
trial remote care services. However, 
the funding was not ring-fenced, 
leading to huge discrepancies in 
levels of remote care spending and 
activity, with some organisations 
progressing well but others making 
little progress. 
Other programmes were set up in 
Scotland and Wales. Between 2006 
and 2011, the Scottish Government 
made £20m available to run the 
Telecare Development Programme 
to increase access to telecare for 
44,000 people22. In Wales, all 22 local 
authorities were awarded funding in 
2006 to provide 10,000 homes with 
a telecare service6. After a slow start, 
Northern Ireland plans to introduce 
telehealth for 3,500 people per year 
over the period 2012-1823.
Following these initiatives, the focus 
shifted away from providing cash 
to kick start projects to generating 
evidence of clinical and cost 
effectiveness. This was seen as 
critical in providing support for those 
making remote care investment 
decisions and those using it, both 
clinicians and the public.  
The Whole System Demonstrators 
programme was therefore 
established, with funding from the 
Department of Health, to provide 
‘gold standard’ evidence of whether 
remote care benefits individual 
users, can deliver significant health 
improvements and is a cost effective 
means of future care delivery24. The 
programme included what is thought 
to be the largest randomized control 
trial of remote care undertaken so 
far, involving over 6000 patients and 
238 GP practices across three sites 
in England. The telehealth part of the 
trial focused on diabetes, chronic 
heart failure and chronic obstructive 
pulmonary disease25. 
Remote care remains firmly on the 
policy agenda following WSD.  The 
DALLAS (Delivering Assisted Living 
Lifestyles at Scale) programme is 
funded with £23m by the Technology 
Strategy Board, National Institute 
for Health Research, the Scottish 
Government, Highlands and Islands 
Enterprise and Scottish Enterprise. 
It aims to establish three to five 
communities of 10,000 people each 
or more across the UK showing 
how assisted living technologies and 
services can be used to promote 
well-being and provide high quality 
health and social care, enabling 
people to live independently. The 
3millionlives initiative was established 
in late 2011 as a collaboration 
between the private sector and health 
and social care authorities to ensure 
that 3 million patients benefit from 
telehealth between 2011 and 2016. 
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The HaCIRIC online library (www.haciric.org/library/haciric-publications)
The HaCIRIC website provides access to all publications developed as a result of our 
research work, as well as links to material developed by others in the field.
These include the following:  
Adaptability and innovation 
in healthcare facilities: 
lessons from the past for 
future developments 
James Barlow, Martina Köberle-
Gaiser, Ray Moss, Ann Noble, Peter 
Scher, Derek Stow: HaCIRIC, The 
Howard Goodman Fellowship. 
September 2009 Reviews capacity 
for innovation in PFI hospital building 
programme, contrasts it with earlier 
NHS hospital building programmes 
and suggests lessons for the future.
How should we create 
21st century healthcare 
infrastructure to deliver  
best value?
Our HaCIRIC Insights document, 
published in September 2011, 
sets out key findings and expertise 
developed during Phase 1 of 
the HaCIRIC programme. The 
document details how HaCIRIC is 
expanding the evidence base linking 
infrastructure and health outcomes, 
improving decision-making and 
helping to future-proof healthcare 
infrastructure.
Better Health Through 
Better Infrastructure
This report reviews the Centre’s 
projects and sets out a vision for the 
future of HaCIRIC.
Meeting Tomorrow’s 
Healthcare Challenges Today:
HaCIRIC September 2010. Sets out 
the four big issues on which HaCIRIC 
is focussing – safer patients, home 
not hospital, smarter purchasing and 
better decision-making.
Complex Healthcare  
Made Simpler
HaCIRIC September 2012:  
Advances and opportunities in 
improving healthcare delivery using 
modelling and simulation.
Controlling Healthcare 
Acquired Infection
HaCIRIC September 2012: New 
learning on how performance 
management and design can  
reduce HCAI.
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